SuperNova Diagnostics Enters Agreement with KSB Diagnostics of China

(Germantown, MD, USA; and London, United Kingdom), a privately-held global diagnostics company for human and nonhuman health applications, signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd. (KSB; Shenzhen, China), a biotechnology diagnostics company specializing in research, manufacture, and distribution of in vitro diagnostic kits and research reagents in China and affiliated markets. Financial terms of the agreement were not disclosed.

AmpCrystal, SuperNova Diagnostics' lead technology with multiple product formats, allows minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes. It can detect directly unamplified DNA in human, animal, or environmental samples. AmpCrystal is hyper-dense, energy-mediated nanocrystals that can be utilized in a wide variety of diagnostic applications and configurations. The technology platform lends itself to both forward-integration into new product formats as well as backward compatible into existing open and closed diagnostic systems.

With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), AmpCrystal technology is simpler, more robust, faster, and significantly less expensive than existing POC systems.

A powerful nanochemistry, AmpCrystal, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without polymerase chain reaction (PCR) with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements. SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtiter, microarrays, closed systems, research products, and OEM).

"We are delighted to announce this agreement with KSB Diagnostics, a leader in China and Asia for diagnostics," said Neil Campbell, president & CEO of SuperNova Diagnostics. "This collaborative relationship allows SuperNova and KSB to expand R&D, manufacturing, and commercialization into one of the world's largest markets."

Through cooperation with its worldwide partners and introduction of advanced technology in the world, Shenzhen Kang Sheng Bao Bio-Technology Co. Ltd. provides the innovating diagnostic kits. Its goals are to make great efforts to serve the rapidly developing market in China and become one of the well-known corporations in the field of in vitro diagnostic reagents.

Related Links:
SuperNova Diagnostics, Inc.
Kang Sheng Bao Bio-Technology Co., Ltd.